1例长期血液透析合并房颤行永久起搏器植入术患者抗凝治疗的临床药学服务  

Clinical Pharmaceutical Care for Anticoagulation Therapy of a Patient with Pace Marker Implantation for Atrial Fibrillation on Chronic Hemodialysis*

作　　者：刘丽 谭喜莹[2] 陈素英 石磊[2] 宋佳伟 陈慧娟[1] LIU Li;TAN Xiying;CHEN Suying;SHI Lei;SONG Jiawei;CHEN Huijuan(People's Hospital of Bozhou,Bozhou,Anhui 236800,China;Jiangsu Province Hospital of Chinese Medcine,Nanjing 210029,China;Jiangyan Hospital of Chinese Medicine,Jiangyan 225500,China)

机构地区：[1]亳州市人民医院临床药学中心,安徽亳州236800 [2]江苏省中医院药学部,南京210029 [3]姜堰市中医院药学部,姜堰225500

出　　处：《药学与临床研究》2023年第2期185-187,共3页Pharmaceutical and Clinical Research

基　　金：江苏省药学会恒瑞医院药学基金科研项目(H202021)。

摘　　要：1例患者长期血液透析合并房颤,行永久起搏器植入术后服用利伐沙班致伤口出血,药师评估其出血严重程度,建议停用丹参多酚酸盐和利伐沙班,改用华法林或阿哌沙班,医生采纳,患者接受华法林治疗,并于第21天出院。One patient took rivaroxaban after pace marker implantation,which caused major bleeds.The pharmacist assessed the severity of bleeding and suggested stopping salvianolate injection and rivaroxaban,and switching rivaroxaban to warfarin or apixaban.The doctor adopted the suggestion.The patient accepted wafarin and was discharged on the 21st day.

关 键 词：房颤 血液透析 抗凝方案 药学服务 

分 类 号：R969.3[医药卫生—药理学]